Stock listing

REG Stock Price, News, Filings & Events — Remegen Co. Ltd. Class A

Selected listing: REG · TRADEGATE · EUR · DE

The selected listing for Remegen Co. Ltd. Class A is REG:TRADEGATE. Remegen is a biopharmaceutical company focused on developing innovative therapies for cancer and autoimmune diseases. Recent news highlights their ongoing clinical trials and advancements in drug development. Investors can find the latest filings and updates on corporate events that may impact the company's market position.

REG:TRADEGATEEURDEUpdated July 21, 2026
Remegen Co. Ltd. Class A logo
Ticker
REG:TRADEGATE
Asset type
Stock
Market cap
$9.44B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TRADEGATE
Currency
EUR

Remegen Co. Ltd. Class A REG:TRADEGATE stock context

The selected listing for Remegen Co. Ltd. Class A is REG:TRADEGATE. Remegen is a biopharmaceutical company focused on developing innovative therapies for cancer and autoimmune diseases. Recent news highlights their ongoing clinical trials and advancements in drug development. Investors can find the latest filings and updates on corporate events that may impact the company's market position.

Research Remegen Co. Ltd. Class A

Alternate listings